Background
==========

Diabetic muscle infarction (DMI) poses a diagnostic dilemma, due to its rare presentation and large differential diagnosis. Diabetic neuropathy is well recognized, with the typical symptoms of distal pain and paresthesiae in the feet and lower legs. Diabetic lumbosacral radiculoplexus neuropathy may present with acute onset severe proximal thigh pain and weakness.[@b1-dmso-12-285] Generalized proximal weakness can also occur as part of the motor presentation of diabetic neuropathy, in association with severe vitamin D deficiency, or hypothyroidism. Rhabdomyolysis, especially due to statins, should be considered when weakness is accompanied by severe and constant pain.

Presenting complaint
--------------------

A 50-year-old male with type 2 diabetes presented with unilateral, then bilateral thigh pain with localized swelling and tenderness.

History of presenting complaint
-------------------------------

Four days prior to admission, the patient had awoken from sleep with acute onset, severe localized pain (VAS =7/10) in the distal and medial aspect of the right thigh. The pain was exacerbated by leg movement and walking. There were no associated prodromal symptoms. He denied a history of physical trauma, excessive exertion, or strenuous sporting activity. He was diagnosed with "muscle strain" and discharged home with analgesia and advised to rest. Two days later, severe pain developed in the proximal lateral part of his left thigh, the pain in the right thigh had increased in severity, and he had developed localized swelling and erythema.

Past medical history
--------------------

The patient had type 2 diabetes mellitus for 18 years, hypertension for 5 years, and had significant proteinuria with chronic kidney disease (CKD). He had undergone laser photocoagulation for diabetic retinopathy (DR) in both eyes 12 years ago, and developed blindness in the left eye due to advanced proliferative DR. The patient had severe neuropathy and had previously undergone a surgical incision to drain pus from an infected left foot ulcer to remove glass foreign bodies.

Medication
----------

1.  Insulin Mixtard 30/70, 33 units am and 30 units pm

2.  Amlodipine 5 mg once a day

3.  Omeprazole 20 mg once daily

4.  Vitamin D3, 50,000 units (1.25 mg) twice weekly

5.  Bisacodyl 5 mg once daily

6.  Bulk laxative powder 3.5 g once daily

Allergies
---------

None elicited.

Family history
--------------

Maternal history of diabetes mellitus and hypertension.

Social history
--------------

The patient was married and retired. He was a non-smoker and did not drink alcohol.

Review of systems on admission
------------------------------

Patient distress was apparent due to intense bilateral thigh pain. There was no history of fever, night sweats or chills, and no recent weight loss. He had visual loss in the left eye due to severe DR. Early morning nausea and vomiting had occurred daily 1 week prior to admission. Pain had limited his ability to walk and he had avoided climbing stairs as it exacerbated the discomfort.

Physical examination
--------------------

Vital signs: temperature 36.5°C, pulse 75/minute, respiratory rate 14/minute, supine blood pressure 150/80, weight: 95 kg, height: 182 cm, BMI: 28.7 kg/m^2^.

The patient was awake, alert, and oriented for time, place, and person. Cranial nerves were intact, and his left eye perceived only light and dark, with pupils equal and reactive to light and accommodation. Fundoscopy confirmed cotton wool exudates in both eyes. Hearing appeared normal in both ears, and his gag reflex was normal.

There was no clubbing, cyanosis, or pedal edema. He had localized erythema and swelling of the medial aspect of the right distal thigh and lateral aspect of the left proximal thigh, with severe tenderness on palpation of the swollen areas. Neurological examination of the lower limbs demonstrated reduced light touch sensation over both feet, with normal Babinski responses. Muscle strength in the upper extremities was normal (Medical Research Council Scale for muscle strength =5/5). Assessment of muscle strength in both legs was limited by intense leg pain, which markedly reduced knee flexion in both legs. His gait could not be assessed, due to severe pain on standing.

Laboratory investigations
-------------------------

Erythrocyte sedimentation rate, creatine kinase, and myoglobin levels were elevated, and there was evidence of chronic anemia and CKD with poor glycemic control ([Table 1](#t1-dmso-12-285){ref-type="table"}).

Imaging
-------

A plain X-ray of his thighs, to exclude an underlying fracture, demonstrated a subtle increased density in the soft tissue of both, but was otherwise unremarkable. Targeted ultrasound of both thighs ([Figure 1](#f1-dmso-12-285){ref-type="fig"}) was undertaken to exclude a muscle tear, or the presence of infection with abscess formation. There was a loss of striations in the skeletal muscles in the right thigh (red arrow), with generalized, particularly subcutaneous edema (blue arrow). The left side demonstrated normal linear muscle striations.

A coronal T1 (non-fat saturated) scan, without contrast, demonstrated right-sided muscle swelling combined with a subtle loss of intramuscular fat striations (red arrow) when compared with the contralateral side (blue arrow) ([Figure 2](#f2-dmso-12-285){ref-type="fig"}). Axial STIR imaging demonstrated extensive T2 hyperintensity in the right thigh muscles, in keeping with extensive edema. The right *vastus medialis* muscle was affected (red arrow), and adjacent right-sided musculature was also involved to a lesser extent, with extensive subcutaneous edema (blue arrow). The left side primarily involved the *vastus lateralis* muscle (green arrow) and had accompanying subcutaneous edema (yellow arrow) ([Figure 3](#f3-dmso-12-285){ref-type="fig"}). The sagittal STIR image confirmed edema in the right *vastus medialis* (red arrow) ([Figure 4](#f4-dmso-12-285){ref-type="fig"}).

Doppler ultrasound of the upper and lower legs excluded deep vein thrombosis. A chest X-ray showed a normal cardiothoracic ratio, albeit with mild bilateral pulmonary infiltrates, but no evidence of heart failure. An EKG showed a normal sinus rhythm with no axis deviation. Echocardiography revealed mild inferior cardiac wall hypokinesia, normal left ventricular systolic function with an ejection fraction of 55%, grade 2 left ventricular diastolic dysfunction, left atrial enlargement, mild septal hypertrophy, a right ventricular systolic pressure of 26 mm Hg, and a mild pericardial effusion. Ultrasound of the kidneys demonstrated normal renal size with no evidence of hydronephrotic obstruction.

Discussion
==========

DMI commonly presents with pain and swelling in the proximal lower limb muscles due to spontaneous infarction of skeletal muscle, but is not related to arterial occlusion.[@b2-dmso-12-285]--[@b8-dmso-12-285] It characteristically presents in patients with a long duration of either type 1 or type 2 diabetes, often accompanied by other microvascular complications, particularly CKD, although the outcomes are not different to those with normal renal function.[@b9-dmso-12-285] It may rarely be painless and can occur in the distal lower limb.[@b10-dmso-12-285]--[@b12-dmso-12-285] The differential diagnosis includes inflammatory myopathy; infection; polymyositis; dermatomyositis; deep vein thrombosis; trauma; soft tissue hemorrhage; necrotizing fasciitis; and diabetic lumbarsacral radiculoplexopathy.[@b1-dmso-12-285],[@b13-dmso-12-285] Our patient had a long duration of type 2 diabetes with poor glycemic control (HbA1c =10.4%), and evidence of all the long-term microvascular complications. Interestingly, he had an elevated creatine kinase and serum myoglobin, indicative of significant muscle pathology, which has previously been shown to be only mildly elevated.[@b14-dmso-12-285] He did have significantly impaired renal function, but was not on a statin, excluding statinrelated rhabdomyolysis.

MRI imaging is the diagnostic modality of choice.[@b15-dmso-12-285]--[@b17-dmso-12-285] The patient had typical changes on his MRI, the affected muscle showing a heterogeneous appearance with hyperintense signals on T2-weighted, STIR sequences, and a hypointense signal on T1-weighted images with loss of normal fatty intramuscular septae, and subcutaneous and perifascial edema.[@b5-dmso-12-285],[@b15-dmso-12-285]--[@b18-dmso-12-285] Muscle biopsy is not recommended, but typically shows muscle fiber necrosis, inflammatory cell infiltrates, and hyalinization of the blood vessels with luminal narrowing.[@b14-dmso-12-285]

There are currently no clear recommendations in the management of DMI, due to a lack of prospective studies. Indeed, a recent systematic review concluded that the literature on DMI is limited to case reports and case series, with very few prospective studies in relation to management.[@b13-dmso-12-285] The authors identified 110 peer-reviewed publications on "*Diabetic muscle infarction*", published between 1972 and 2018. Previous articles have outlined the presentation and complications of DMI, but none have provided a decision tree or an algorithm on the management of DMI. The authors developed a decision tree identifying those at highest risk of DMI, and indicated the relevant investigations and management for DMI ([Figure 5](#f5-dmso-12-285){ref-type="fig"}).

A limited retrospective analysis showed that, when comparing surgery, physiotherapy, and bed rest, the mean time to recovery from DMI being diagnosed was 149, 71, and 43 days, and the mean time to recurrence was 30, 107, and 297 days, with a recurrence rate of 57%, 44%, and 24%, respectively, indicating that bed rest is the best treatment option.[@b19-dmso-12-285] Surgery should be avoided as it is associated with increased morbidity and delayed recovery.[@b20-dmso-12-285] Optimization of glycemic control and vascular risk factors is recommended, but is not supported by evidence.

Conclusion
==========

DMI in a patient with diabetes is often misdiagnosed. A careful history is imperative, particularly when the onset of pain is acute and severe, without associated trauma. MRI is the investigation of choice, and an invasive muscle biopsy is unnecessary.

Patient's perspective
---------------------

Neither the patient nor the initial ER physicians had linked the proximal limb pain to diabetes, as diabetic neuropathy typically presents with distal symmetrical dysesthesia and paresthesia.[@b1-dmso-12-285] However, the patient questioned the diagnosis of "muscle strain", especially as the pain awoke him from sleep, was not relieved by conventional analgesia, and then developed in the other thigh.

Confidentiality
===============

The patient provided verbal and written, informed consent for the use of medical information for publication.
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![Ultrasound scan targeted on the thigh demonstrates some loss of definition of the normal muscular striations on the right side (red arrow), with an increase in generalized edema, particularly subcutaneous edema (blue arrow).\
**Note:** The left side was also scanned, which demonstrates the normal linear striations expected within skeletal muscle (green arrow).](dmso-12-285Fig1){#f1-dmso-12-285}

![Coronal T1 (non-fat saturated) MRI scan demonstrates right sided muscular swelling combined with subtle loss of the intramuscular fat striations (red arrow) when compared with the contralateral side (blue arrow).\
**Abbreviation:** MRI, magnetic resonance imaging.](dmso-12-285Fig2){#f2-dmso-12-285}

![Axial STIR image demonstrates extensive T2 hyperintensity in the right thigh musculature, in keeping with extensive edema.\
**Notes:** Most notably, the right *vastus medialis* (VM) muscle is affected (red arrow). Adjacent musculature is affected to a lesser extent. Extensive subcutaneous edema noted (blue arrow). The left side is also affected with similar edema, though to a much lesser extent, mainly affecting the *vastus lateralis* (VL) (green arrow) and a degree of adjacent subcutaneous edema (yellow arrow).](dmso-12-285Fig3){#f3-dmso-12-285}

![Sagittal STIR image demonstrating the extent of right *vastus medialis* edema (red arrow).](dmso-12-285Fig4){#f4-dmso-12-285}

![Decision tree for the diagnosis and management of diabetic muscle infarction.\
**Abbreviations:** DMI, diabetic muscle infarction; Dx, differential diagnosis; DVT, deep vein thrombosis; ESRD, end stage renal disease; MRI, magnetic resonance imaging.](dmso-12-285Fig5){#f5-dmso-12-285}

###### 

Laboratory investigations

  Test                            Result                                            Normal values
  ------------------------------- ------------------------------------------------- ------------------
  Hgb (g/dL)                      10.5[a](#tfn1-dmso-12-285){ref-type="table-fn"}   14--18
  WBC ×10^9^/L                    11.1[a](#tfn1-dmso-12-285){ref-type="table-fn"}   3.5--12.0
  RBC ×10^12^/L                   3.9                                               4.6--6.2
  HbA1c (%)                       10.4[a](#tfn1-dmso-12-285){ref-type="table-fn"}   3.0--5.6
  Hct (%)                         32.3[a](#tfn1-dmso-12-285){ref-type="table-fn"}   40--54
  MCV (fL)                        82                                                76--100
  MCH (pg)                        27                                                27--34
  Platelets ×10^9^/L              333,000                                           135,000--400,000
  Glucose (mmol/L)                9.6[a](#tfn1-dmso-12-285){ref-type="table-fn"}    3.9--5.6
  BUN (μmol/L)                    27.4[a](#tfn1-dmso-12-285){ref-type="table-fn"}   2.5--8.0
  Creatinine (mmol/L)             760[a](#tfn1-dmso-12-285){ref-type="table-fn"}    70--120
  Sodium (mmol/L)                 143                                               135--145
  Potassium (mmol/L)              3.5                                               3.5--5.0
  Chloride (mmol/L)               105                                               98--106
  Bicarbonate (mmol/L)            22                                                24--30
  Bilirubin (mg/L)                3.8                                               \<8
  Amylase (U/L)                   64                                                \<160
  ALT (U/L)                       17                                                17--63
  AST (U/L)                       22                                                18--40
  Creatine kinase (IU/L)          1600[a](#tfn1-dmso-12-285){ref-type="table-fn"}   20--215
  Serum myoglobin (ng/mL)         854[a](#tfn1-dmso-12-285){ref-type="table-fn"}    0--85
  ESR (mm/hr)                     126[a](#tfn1-dmso-12-285){ref-type="table-fn"}    0--22
  Urinary sodium (mmol/day)       83                                                25--260
  Urinary creatinine (mmol/day)   6.4[a](#tfn1-dmso-12-285){ref-type="table-fn"}    8.8--17.6
  FENa (%)                        7[a](#tfn1-dmso-12-285){ref-type="table-fn"}      \<2
  Albumin/creatinine ratio        444[a](#tfn1-dmso-12-285){ref-type="table-fn"}    \<3.4
  TIBC (μmol/L)                   60                                                45--82
  Ferritin % saturation (μg/L)    8.3[a](#tfn1-dmso-12-285){ref-type="table-fn"}    24--336
  Iron (%)                        5                                                 4--6
  Urine pH                        5.5                                               4.6--8.0
  Urinary protein (mg/day)        2+[a](#tfn1-dmso-12-285){ref-type="table-fn"}     10--150
  Urinary glucose (mmol/L)        1+[a](#tfn1-dmso-12-285){ref-type="table-fn"}     0--0.8

**Note:** Abnormal results.

**Abbreviations:** ALT, alanine aminotransferase; AST, aspartate aminotransferase; BUN, blood urea nitrogen; ESR, erythrocyte sedimentation rate; FENa, fractional excretion of sodium; HbA1c, glycated haemoglobin; Hct, haematocrit; Hgb, haemoglobin; MCH, mean corpuscular haemoglobin; MCV, mean corpuscular volume; RBC, red blood cell; TIBC, total iron binding capacity; WBC, white blood cell.
